Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep155 | Endocrine tumours and neoplasia | ECE2017

False positive findings on 6-[18F]fluor-L-3,4-dihydroxyphenylalanine Positron Emission Tomography (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors

Berends MA , Bolt JW , Kerstens MN , Links TP , Korpershoek E , de Krijger RR , Walenkamp AME , Noordzij W , van Etten B , Kats-Urgurlu G , Brouwers AH , van der Horst-Schrivers ANA

Background/Aim: Neuroendocrine tumors (NETs) are rare tumors arising from neuroendocrine cells throughout the body. Positron Emission Tomography (PET) scanning with 6-[18F]fluor-L-3,4-dihydroxyphenylalanine (18F-FDOPA) has been shown to be a valuable technique for the imaging of NETs. While the sensitivity has been assessed numerously, studies systematically describing false positive results, other than physiological variants, are lacking. Our aim was to systematica...

ea0041ep807 | Obesity | ECE2016

Changes in SCD1 promoter DNA methylation after bariatric surgery in morbid obese patients are associated with free fatty acids levels

Morcillo Sonsoles , Martin-Nunez Gracia Ma , Garcia-Serrano Sara , Gutierrez-Repiso Carolina , Rodriguez-Pacheco Francisca , Ho-Plagaro Ailec , Alaminos-Castillo Miguel A , Valdes Sergio , Gonzalo Motserrat , Moreno-Ruiz Francisco J. , Montiel-Casado Custodia , Rodriguez-Canete Alberto , Garcia-Fuentes Eduardo

Introduction: Epigenetic is acquiring great importance in complex diseases, providing mechanisms whereby environmental factors can influence complex diseases such as obesity and type 2 diabetes. Experimental animal and human studies have revealed the association between SCD1 and obesity and insulin resistance. The aim of this study was to evaluate whether metabolic changes after intervention are associated with DNA methylation pattern and if these changes are related to weigh ...

ea0059oc3.5 | Obesity & diabetes | SFEBES2018

Hypothalamic arcuate glucokinase and its downstream pathways are critical in glucose homeostasis

Ratnasabapathy Risheka , Ma Yue , Izzi-Engbeaya Chioma , Nguyen-Tu Marie-Sophie , Richardson Errol , Hussain Sufyan , De Backer Ivan , Holton Christopher , Norton Mariana , Carrat Gaelle , Schwappach Blanche , Rutter Guy A , Dhillo Waljit S , Gardiner James V

As the nation gets fatter, the incidence of diabetes is also rising. The brain is now emerging as a critical mediator of blood sugar control, re-directing focus away from the traditional pancreas-centred model. The enzyme glucokinase (GK) acts as a glucose sensor in many tissues including glucose-sensitive neurones within the hypothalamic arcuate nucleus. However, the role of GK here is unclear. We investigated the role of arcuate GK in glucose homeostasis in both healthy and ...

ea0070aep294 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Fibroblast growth factor 21 (FGF21) in hyper- and hypothyroidism, association with metabolic disturbances

Szczepańska Ewa , Gietka-Czernel Małgorzata , Glinicki Piotr , Jastrzębska Helena , Słowińska-Srzednicka Jadwiga , Kapuścińska Renata , Zgliczyński Stefan , Zgliczyński Wojciech

Background: FGF21 is a critical metabolic regulator with beneficial effects on lipid and glucose metabolism. FGF21 is produced primarily by the liver and stimulates fatty acids oxidation, which prevents hepatic triglycerides accumulation and nonalcoholic fatty liver disease (NALFD). FGF21also increases insulin sensitivity and glucose uptake in adipose tissue. Paradoxically FGF21 is elevated in insulin resistance states e.g. NALFD, obesity and type 2 diabetes. It is not determi...

ea0070aep629 | Pituitary and Neuroendocrinology | ECE2020

The time, mode and markers of pituitary function deterioration in patients with PROP1 mutation. Single centre, longitudinal observation

Gilis-Januszewska Aleksandra , Rogoziński Damian , Kluczyński Łukasz , Godlewska Magdalena , Bogusławska Anna , Piwońska-Solska Beata , Zygmunt-Górska Agata , Wójcik Małgorzata , Starzyk Jerzy , Hubalewska-Dydejczyk Alicja

Introduction: The mode of pituitary function deterioration in patients with PROP1 mutation is not fully known and understood. The function of adrenal axis requires special attention.Aim: To investigate the time/mode/markers of pituitary function deterioration in families/sporadic patients with PROP1 mutation during longitudinal observation.Methods: We performed retrospective longitudinal (36.4 years, s.d. = 13.6) analy...

ea0070aep690 | Pituitary and Neuroendocrinology | ECE2020

Metabolic abnormalities in patients with childhood onset of hypopituitarism – single center,long term observation

Kluczyński Łukasz , Gilis-Januszewska Aleksandra , Rogoziński Damian , Godlewska Magdalena , Pantofliński Jacek , Zygmunt-Górska Agata , Wójcik Małgorzata , Starzyk Jerzy , Hubalewska-Dydejczyk Alicja

Background: Hypopituitarism is a condition caused by deficiency in one or multiple pituitary hormones. The disease is associated with various metabolic disorders and decreased quality of life that are particularly marked in patients with childhood onset of the disorder. There are manyfactors influencing the metabolic status of patients such as different treatment modalities (surgery, radiotherapy, chemotherapy) and current supplementation (e.g. steroid or testosterone/estradio...

ea0070aep745 | Pituitary and Neuroendocrinology | ECE2020

The characteristic of patients with pituitary stalk lesions – single center,long term observation

Kluczyński Łukasz , Gilis-Januszewska Aleksandra , Rogoziński Damian , Godlewska Magdalena , Pantofliński Jacek , Zygmunt-Górska Agata , Wójcik Małgorzata , Starzyk Jerzy , Hubalewska-Dydejczyk Alicja

Background: Pituitary stalk lesions (PSL) is a general term used to describe changes located in the pituitary infundibulum. Special anatomical locus makes the diagnosis difficult to establish. Most of the patients with PSL characterizes with hypopituitarism and multiple metabolic abnormalities.Aim: To present the characteristic of patients with PSL.Methods: We analyzed data of 35 patients (21 M/14 W) with pituitary stalk ...

ea0070aep867 | Thyroid | ECE2020

Loss of heterozygosity (LOH) at 12q24.11 as a potential marker of follicular thyroid lesions malignancy

Borowczyk Martyna , Szczepanek-Parulska Ewelina , Budny Bartłomiej , Dębicki Szymon , Verburg Frederik , Filipowicz Dorota , Wrotkowska Elżbieta , Gil Lidia , Janicka-Jedyńska Małgorzata , Oszywa Michalina , Ziemnicka Katarzyna , Ruchala Marek

Introduction: Pre- and postsurgical differentiation between follicular thyroid adenoma (FTA) and follicular thyroid cancer (FTC) represents a significant diagnostic challenge. Typical markers of malignancy may appear as specific genetic alterations. Next-generation sequencing (NGS) studies bring information about single point mutations, however better insight into follicular thyroid lesions genetic landscape, encompassing bigger rearrangements, is needed.<p class="abstext"...

ea0020p169 | Thyroid | ECE2009

Frequency of thyroid function test abnormalities in an open population in Queretaro, Mexico

Osorio Ma. Ludivina Robles , Montiel Hebert Luis Hernandez , Sainz Juan Carlos Solis , Solis Pablo Garcia , Silva Ernesto Francisco Sabath , Lomeli Adrian Hernandez , Maya Victor Eduardo , Ramirez Nestor , Gonzalez David , Alcantara Alejandro

It is important to know the prevalence of common diseases in every country in order to guide us to take decisions regarding public health benefits in screening, in Mexico we do not have information regarding thyroid abnormalities.Methods: We designed a cross-sectional study in the city of Queretaro (Mexico) in order to know the prevalence of altered thyroid function tests in our population, since we do not have any previous study. We calculated the sampl...

ea0019oc4 | Young Endocrinologist prize session | SFEBES2009

Kisspeptin potently increases reproductive hormone release in women with hypothalamic amenorrhoea: a potential novel therapy for infertility

Jayasena CN , Chaudhri OB , Nijher GK , Murphy KG , Ranger A , Lim A , Patel D , Mehta A , Todd C , Ramachandran R , Salem V , Stamp GW , Donaldson M , Ghatei MA , Bloom SR , Dhillo WS

Background: Kisspeptin is a critical regulator of normal reproductive function. In humans inactivating mutations of the kisspeptin receptor GPR54 cause hypogonadotrophic hypogonadism and pubertal failure. Activating mutations of GPR54 cause precocious puberty. Hypothalamic amenorrhoea (HA) accounts for over 30% of cases of amenorrhoea in women of reproductive age. Current treatments have limited success rates and side effects. In rodent models of HA hypothalamic KISS1 expressi...